SPRB
Spruce Biosciences, Inc.
45.70$
+2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.1% | -30.7% | -19.6% | -62.6% | +15.8% | +0.0% | -100.0% | – | – | – | – | – | |
| – | -5.9% | -6.3% | +53,833.3% | – | – | – | – | – | – | – | – | – | |
| – | -6.6% | -30.3% | -19.6% | -62.6% | – | – | – | – | – | – | – | – | |
| – | -17.7% | -7.1% | -21.6% | -19.0% | +227.4% | -49.5% | -96.0% | +1,065.3% | -18.1% | +84.6% | +60.6% | – | |
| – | -8.8% | +46.3% | -17.6% | -2.8% | -4.1% | +10.3% | -14.6% | +3.1% | +117.4% | -36.9% | -1.4% | – | |
| – | -16.1% | +4.3% | -20.4% | -14.0% | +147.5% | -41.5% | -81.4% | +205.7% | +34.9% | +8.0% | +37.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.9% | -8.5% | -14.4% | -14.5% | -21.1% | -35.7% | -19.4% | -34.5% | -68.4% | +11,133.3% | +62.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.